INTRODUCTION
For many years sphingomyelin (SPH) has been considered mostly as a structural component of biological membranes. The structural effects depend in part on the particular phase behaviour of SPH and the consequential effects on its interaction with cholesterol. Interest in this phospholipid was renewed when its role as a precursor of a variety of intracellular signalling derivatives was demonstrated [1] . The ceramide backbone, sphingosine and sphingosine 1-phosphate derived from SPH are now recognized as prominent regulatory effectors of cell growth, differentiation and apoptosis [2] .
In addition to this recently recognized regulatory activity, SPH has a particular structural role among the phospholipids of biological membranes, especially in plasma membranes, where it is located preferentially in the outer lipid leaflet. The particularly close association of SPH with cholesterol was noted in early studies of Chapman et al. [3] . This is believed to result from particular features of SPH. The sphingosine hydroxy group at the C-3 position along the ∆4,5-trans double bond and the amide group nitrogen act as hydrogen-bonding sites whose interaction with the 3β-hydroxy group of cholesterol has been reported [4, 5] . The ' condensing ' effect of cholesterol is manifested by a decrease of 10-20 % in the average molecular area occupied by the phospholipid at the aqueous interface of monomolecular films maintained at surface pressures representative of biomembranes. Van der Waals interactions between the long-chain base and cholesterol [6] are considered to have a role similar to that of the sn-1 saturated acyl chain of phosphatidylcholine (PtdCho) in enhancing the cohesive interaction with α-face of cholesterol. Because SPH forms a gel phase at physiological temperatures, there is a close alignment of the extended acyl chain and the planar sterol ring system, which favours van der Waals interactions between the two molecules. Molecular species of SPH are characterized by a high proportion of saturated very long acyl chains amide-bonded to the sphingosine moiety. This contrasts Abbreviations used : DPPC, D-α-dipalmitoylphosphatidylcholine ; GC-MS, gas chromatography-MS ; PtdCho, phosphatidylcholine ; PtdEtn, phosphatidylethanolamine ; PtdSer, phosphatidylserine ; SPH, sphingomyelin ; sPLA 2 , secretory phospholipase A 2 . 1 To whom correspondence should be addressed (e-mail wolf!ccr.jussieu.fr).
cholesterol to SPH liposomes with a 1 : 1 stoichiometry relieves completely the inhibition of sPLA # exerted by SPH. The mechanism of inhibition suggested by the binding assay is that sPLA # binds with affinity to the SPH interface, after either phase segregation at the assay temperature or on the pure SPH liposomes added to the incubation medium. Cholesterol is shown to suppress the binding affinity of the enzyme for the SPH interface. A model for inhibition is suggested in which binding of the sphingosine moiety is competitive for sPLA # (inhibition) or for cholesterol (release of the enzyme).
with the moderately long polyunsaturated chains at the sn-2 position of membrane glycerophospholipids. This results in a high temperature (T m ) for the transition from gel to liquid-crystal phase of sphingolipids, which forces them into separate gel phase domains within a fluid bilayer matrix of glycerophospholipids at physiological temperatures [7] .
A consequence of the close association of SPH with cholesterol in segregated domains of the gel phase is that membrane fractions can be isolated from a number of eukaryotic cells that resist dissociation by mild detergents [8, 9] . The detergent-insoluble fraction, commonly referred to as ' detergent-resistant membranes ' (DRM), was found to contain a variety of membrane proteins involved in signal transduction or lipid trafficking [10, 11] .
It is well known that phospholipases A # (PLA # ) must bind to the water\substrate interface to mount a hydrolytic attack on the susceptible sn-2 ester bond [12] . One of the explanations for the marked resistance of the outer layer of plasma membranes to extracellular phospholipases is that the high packing density of the bilayer leaflet enriched in SPH, PtdCho and cholesterol hinders the penetration of the enzymes into the substrate structure. The notion that SPH is the primary activity-limiting factor has come from studies that have shown a marked stimulation of PLA # activity against biological membranes subjected to pretreatment with bacterial sphingomyelinase [13, 14] . The physiological significance that is usually given to the resistance of the outer layer of the cell membrane to the eventually high level of circulating PLA # during inflammatory syndromes could be a consequence of the lipid composition of the exposed leaflet comprising SPH.
Previously we have observed that enrichment of the rat liver plasma membranes with SPH was followed by a decrease in the membrane-bound PLA # activity [15] . This result is consistent with other studies on the effect of SPH on phospholipid hydrolysis. Dawson et al. [16] , for example, showed that SPH at high concentrations (40 mol %) significantly inhibited the PLA # hydrolysis of intestinal mucosal phosphatidylethanolamine (PtdEtn). Leslie and Channon [17] reported that SPH that had been co-dispersed with arachidonoyl-PtdCho substrate markedly inhibited macrophage PLA # ; they concluded that inhibition was due to an increase in the lipid packing density. Lobo and Wilton [18] observed a strong inhibition of both type I pig pancreatic and Naja naja PLA # when the PtdCho substrate was co-sonicated with 30 mol % SPH. In a study on lecithin : cholesterol acyltransferase, Bolin and Jonas [19] reported ' specific ' competitive inhibition by SPH. For phospholipase C, Scarlata et al. [20] showed that inclusion of SPH in PtdCho\PtdIns(4,5)P # substrate inhibits phospholipase C-δ activity and suggested that it is due to increased interlipid hydrogen bonding, which decreases membrane hydration. The authors also found that SPH itself did not bind phospholipase C-δ ; neither did it affect binding to the PtdIns(4,5)P # substrate. A previous study from this laboratory [21] has reported that SPH inhibited human type II secretory PLA # (sPLA # ) acting on erythrocyte membranes. The action of SPH was not due to a non-specific ' packing density ' or substrate dilution effect because replacement of SPH with the non-hydrolysable enantiomer of disaturated PtdCho, -α-dipalmitoylphosphatidylcholine (DPPC), a membrane ' rigidifier ', did not inhibit the enzyme. The enzyme has a putative role in the release of pro-inflammatory lipid mediators but its direct participation in the release of arachidonic acid is conjectural and could be influenced by the composition of target membranes [22, 23] . The present study was undertaken to characterize the modulation of human sPLA # in membranes containing SPH and cholesterol. In particular, we wished to decipher whether SPH inhibits the enzyme in a specific competitive manner or via an alteration in the physical properties of the substrate. The strategy employed was to assay sPLA # activity with a highly susceptible substrate consisting of a mixed dispersion of PtdEtn\phosphatidylserine (PtdSer) in the presence of liposomes formed from SPH. In this approach, SPH does not alter the physical state of the glycerophospholipid substrate but can interact separately with the enzyme. We conclude that the enzyme binds to SPH liposomes and is thereby diverted from the substrate. The presence of cholesterol in the SPH liposomes decreased the binding affinity of the enzyme and released more enzyme to hydrolyse the substrate.
MATERIALS AND METHODS

Reagents
-α-PtdEtn (from egg yolk), -α-PtdSer (from bovine brain), SPH (from egg yolk), DPPC and cholesterol were purchased from Sigma (St. Louis, MO, U.S.A.). Recombinant type II secretory PLA # collected from C127 transfected mouse fibroblasts overexpressing the human enzyme [24] was generously provided by Dr. Olivier (Faculte! de Me! decine St. Antoine, Paris, France).
Materials
Centricon-100 filters were obtained from Amicon (Beverly, MA, U.S.A.) and were soaked in a 0.1 % albumin solution to prevent non-specific protein adsorption, in accordance with the supplier's recommendations.
Preparation of the erythrocyte ghosts serving as the substrate
Human erythrocytes were isolated from fresh citrated blood [25] . All steps were performed at 4 mC. The blood was centrifuged for 10 min at 100 g. Erythrocytes were collected and washed several times with 5 vol. of PBS, pH 8.0, and haemolysed in 5 mM sodium phosphate buffer, pH 8.0 (40 vol.). The ghosts were collected by centrifugation for 20 min at 22 000 g (Beckman J2-HS), then washed with 5 mM phosphate buffer until ' white ghosts ' were obtained (four cycles). Membrane proteins were measured by using the method of Bradford [26] .
Preparation of liposomes
Liposomes were prepared by sonication of PtdEtn\PtdSer (80 : 20, mol\mol), SPH, SPH\cholesterol or DPPC. Typically, phospholipids were dissolved in chloroform, dried under a stream of oxygen-free dry nitrogen, hydrated in Tris\HCl buffer, pH 8.6, and sonicated (twice for 2 min) with a tip probe (MSE, Crawley, Surrey, U.K.) (20 kHz, approx. 100 W) until a clear dispersion had been obtained.
Binding and filtration procedures
Liposomes of non-hydrolysable phospholipids SPH, DPPC or SPH\cholesterol (1 : 1, mol\mol) and DPPC\cholesterol (1 : 1, mol\mol) were incubated with sPLA # (100 nmol of SPH or DPPC and 3 m-units of sPLA # ). After 10 min the incubations were spun down through a Centricon 100 filter, with the temperature maintained at 37 mC, and filtrates were collected for the determination of unbound sPLA # . We confirmed independently that the filters were permeable to sPLA2 (14 kDa) but excluded SPH, DPPC or SPH\cholesterol and DPPC\cholesterol liposomes.
Phospholipase A 2 assay
PLA 2 activity assayed with erythrocyte membranes
The assay contained erythrocyte membranes representing 100 nmol of hydrolysable glycerophospholipids serving as the substrate in 0.5 ml of 100 mM Tris\HCl (pH 8.6)\10 mM CaCl # \ 0.1 % fatty acid-free BSA. The reaction was initiated with 3 munits of human recombinant type II sPLA # (the activity of the enzyme preparation was calibrated by comparison with a reference activity of pancreatic PLA # ). Incubations were performed for 15 min at 37 mC with translational shaking. Released fatty acids, extracted by a modification of the procedure of Dole [27] and methylated by diazomethane, were quantified by gas chromatography-MS (GC-MS). Control incubations of erythrocyte membranes incubated in the absence of added sPLA # were used to correct the levels of fatty acids released by sPLA # .
PLA 2 activity on phospholipid liposomes
The incubation was performed for 15 min at 37 mC in a final volume of 0.5 ml, containing 100 nmol of hydrolysable phospholipids [PtdEtn\PtdSer (80 : 20, mol\mol)] suspended in 100 mM Tris\HCl (pH 8.6)\10 mM CaCl # \0.1 % BSA. Human recombinant type II sPLA # (3 m-units) was added to start the reaction. The released free fatty acids were extracted, methylated with diazomethane and quantified by GC-MS. Control incubations were performed in the absence of sPLA #
; the values were used to correct the levels of enzyme activity.
Quantitative measurements with GC-MS
The extracted free fatty acids were methylated for 5 min with fresh diazomethane ; methyl esters were separated by gas chromatography on a capillary column wall-coated with Supelcowax-10 bonded phase [internal diam. 0.32 mm, length 30 m, film thickness 0.25 µm (Supelco, Bellafonte, PA, U.S.A.)] fitted in a Hewlett Packard 5890 Series II gas chromatograph. Fatty acids were detected with picomolar sensitivity by MS (Nermag 10-10C ; Nermag, Reuil, France) in the chemical ionization mode with ammonia (10% Pa) as the reagent gas. The positive quasimolecular ions were selectively monitored and time-integrated. Quantification was achieved by reference to an internal standard of heptadecanoic methyl ester with response factors calculated for the various fatty acid methyl ester calibrators.
RESULTS
Inhibitory activity of SPH on sPLA 2
The effect of SPH on the activity of sPLA # is illustrated in Figure  1 . In this experiment the inhibitory effects of SPH on the sPLA # activity were compared when the sphingolipid was added either co-dispersed with the glycerophospholipid substrate or when added separately as liposomes of pure SPH. In both cases the presence of SPH caused inhibition of the release by sPLA # of the various fatty acids from the sn-2 position of the glycerophospholipids. Inhibition reached a plateau (50 % when added separately ; 70 % when co-dispersed) over a molar ratio of 0.5 for SPH\glycerophospholipid. The experiment showed that a 10 min preincubation of the enzyme with SPH before addition of the substrate liposomes reinforced the extent of inhibition for low concentrations of SPH when compared with incubations in which SPH liposomes were added simultaneously with the substrate glycerophospholipids. As discussed below, this is consistent with the binding of the enzyme to SPH liposomes and subsequent progressive release to attack the substrate. In addition, when the enzyme is acting on the mixed liposomes the inhibition is influenced by the potential SPH-binding sites formed.
To test the possibility that sPLA # interacts transiently with the substrate and the SPH surface throughout the incubation an experiment was performed in which SPH liposomes were added 
Figure 3 Inhibition by SPH of sPLA 2 acting on erythrocyte membranes
Erythrocyte membranes (100 nmol of glycerophospholipids) were incubated in the presence of 3 m-units of sPLA 2 . Various quantities of SPH liposomes were present during the 15 min incubation at 37 mC, after which the released fatty acids were quantified by GC-MS as described in the legend to at different intervals after initiation of the reaction (final SPH-toglycerophospholipid molar ratio, 1 : 1). The results in Figure 2 show that there was an inhibition of hydrolysis of the glycerophospholipid that depended on the length of time that the SPH liposomes were present in the reaction mixture. The magnitude of inhibition was greatest if SPH liposomes were added within 2 min of initiation of the reaction ; the inhibition decreased as the reaction progressed.
The effect of SPH on the activity of sPLA # acting on a natural substrate was examined next. Such assays are possible with the GC-MS method, which monitors the fatty acids produced by the hydrolytic activity from any (unlabelled) substrate with great sensitivity. Figure 3 shows that the addition of SPH liposomes Table 2 Binding of sPLA 2 
to SPH liposomes
The relative binding affinity of sPLA 2 was judged by hydrolytic activity measured in the filtrate of enzyme (3 m-units) incubated with sonicated liposomes of SPH (100 nmol), SPH (100 nmol)/cholesterol (10 or 100 nmol), DPPC (100 nmol) or DPPC (100 nmol)/cholesterol (100 nmol). Unbound enzyme was separated by centrifugation through a Centricon-100 filter at 37 mC. The filtrate was assayed for sPLA 2 gave a strong inhibition of sPLA # acting on biomembranes. The enzyme was completely inhibited at an estimated SPH-tohydrolysable phospholipid ratio of 2 : 1, taking into account the SPH content of human erythrocyte membranes (20 mole % of total membrane phospholipids).
The effect of hydrolysis of SPH in substrate mixtures was investigated next. Pretreatment of substrate\SPH liposomes with sphingomyelinase from Staphylococcus aureus essentially restored sPLA # activity to levels observed in substrate dispersed in the absence of SPH (100 % released fatty acids in the absence of SPH ; 31 % in the presence of SPH ; 83 % after pretreatment with sphingomyelinase). The ceramide products that resulted from hydrolytic cleavage of the phosphocholine group were likely to remain in the glycerolipid substrate [28] .
A number of studies have indicated that SPH binds more strongly to cholesterol than do most of the glycerophospholipids [29] . Because a physiological significance is inferred from this molecular association in detergent-resistant biomembrane fractions, we examined the inhibitory effect of SPH on sPLA # in the presence of cholesterol. The results presented in Table 1 show that the inclusion of cholesterol in the SPH\glycerophospholipid substrate mixture decreased the inhibitory effect of SPH on the enzyme. When cholesterol was present in equimolar amounts with SPH, no inhibition was detected. A control experiment showed that cholesterol co-sonicated with PtdEtn\PtdSer alone did not influence sPLA # susceptibility in the absence of SPH. Relief of the inhibition was also observed if cholesterol was initially co-dispersed with the glyceropholipid substrate and SPH liposomes were added separately. The effect of cholesterol in this case was much decreased, suggesting that progressive transfer of cholesterol from the substrate to the SPH liposomes might be required for cholesterol to prevent inhibition of the enzyme by SPH.
An interesting observation in these experiments was that the composition of the hydrolysate was enriched in polyunsaturated fatty acids compared with mono-unsaturated oleic acid when cholesterol was added to SPH\glycerophospholipid liposomes. The shift in the composition of the released fatty acids was consistent with decreased protection by cholesterol of the saturated and mono-unsaturated molecular species of glycerophospholipid initially associated with SPH into domains with ' detergent-resistant membrane ' properties, as suggested by previous physical studies [30] . It could be envisaged that sPLA # has a lowered binding affinity for these cholesterol\glycerophospho-lipid\SPH domains and therefore the enzyme is available for hydrolysis of the polyunsaturated molecular species of the surrounding glycerophospholipids.
To test the suggestion that phase-separated domains of SPH (or pure SPH liposomes) might compete with glycerophospholipid for the binding of sPLA # , enzyme binding studies were performed. Initially, liposomes of SPH were incubated with sPLA # to assess the binding capability of the sphingolipid. After liposomes had been mixed with the enzyme, the dispersions were centrifuged through Centricon 100 filters, which exclude sPLA # bound to liposomes. The results presented in Table 2 show that 40 % of the sPLA # activity was retained on the SPH liposomes under the experimental conditions used. A control experiment showed that all of the sPLA # activity could be recovered after filtration through an albumin-soaked filter and that no SPH was detectable in the filtrate. When SPH\cholesterol liposomes were substituted for pure SPH liposomes, the affinity of the enzyme for the liposomes was decreased and virtually all of it was recovered in the filtrate for liposomes consisting of an equimolar ratio of SPH and cholesterol. DPPC and DPPC\cholesterol liposomes did not seem to bind the enzyme either.
DISCUSSION
The present study was instigated in view of previous results indicating that the inhibition of secretory PLA # by SPH was apparently not due to any alteration in the fluidity of the phospholipid matrix serving as substrate [21] . The increase in packing density and viscosity of the phospholipid hydrocarbon domain due to the effect of SPH cannot explain the low accessibility or activity of the enzyme on the sn-2 ester bond of the substrate at the lipid\water interface. Experiments performed with a non-hydrolysable enantiomeric disaturated PtdCho, DPPC, that is able to rigidify glycerophospholipid bilayers to about the same extent as SPH had no effect on activity of sPLA # [21] . Because a non-specific effect of SPH seemed to be ruled out, it follows that the inhibition of sPLA # results from a more specific effect of SPH on the reaction.
A simple experiment to investigate the nature of specific inhibition is to add SPH as pure liposomes to the incubation during the assay of sPLA # rather than as a co-dispersion with the glycerophospholipid substrate. The substrate mixture PtdEtn\ PtdSer (80 : 20, mol\mol) was selected for the present experiments because of its high susceptibility to hydrolysis. This susceptibility is assumed to explain the attack of biomembranes by the hydrolytic enzyme after the ' scrambling ' of phospholipid asymmetry associated with cell activation [31] . The susceptibility relies on the anionic character of PtdSer, which is claimed to favour the binding of sPLA # . We observed that SPH inhibits sPLA # irrespectively of whether the sphingolipid is co-dispersed with the substrate before the incubation or is added separately as pure liposomes. Moreover inhibition is immediate as soon as SPH is present in the assay incubation. This seems to exclude fusion of the stable SPH liposomes with the PtdEtn\PtdSer substrate dispersion as a prerequisite for inhibition of sPLA # , given the short duration of the assay. Small-angle X-ray diffraction of SPH co-dispersed with PtdEtn\PtdSer has shown a lamellar phase (C. Wolf, K. Koumanov and P. J. Quinn, unpublished work). Under the experimental conditions used here (37 mC), mixed liposomes or pure SPH liposomes probably offer similar phase-segregated gel SPH (T m $ 40 mC) interfaces available for interaction with sPLA # [32] . We suggest that the PtdEtn\PtdSer substrate is altered to an arrangement of two distinct lamellar phases by the addition of SPH. In the absence of cholesterol, the interface created by pure SPH could compete with the substrate glycerophospholipids for binding of sPLA # . When SPH liposomes are added after the substrate during enzyme assay, the sPLA # activity is decreased very rapidly, indicating that the enzyme can be readily displaced from the interface of the hydrolysable substrate by presentation of nonhydrolysable sphingolipid. Phase-segregated SPH within mixed liposomes or pure SPH liposomes might serve similarly to bind and detain the enzyme on its interface. This could provide a mechanism whereby enzyme activity is regulated by the partition of sPLA # between the SPH interface and PtdEtn\PtdSer. The affinity of the enzyme for a pure SPH interface has been demonstrated by filtration : significant amounts of sPLA # seem to be adsorbed on non-filtrating liposomes under the experimental conditions used for the enzyme assay. The fact that cholesterol is able to restore the filterability of sPLA # (14 kDa) suggests a mechanism for the dynamic control of the affinity of the enzyme for SPH surfaces.
The reason for the lack of affinity of sPLA # for SPH\cholesterol lamellae remains unclear. It could be that the sphingosine moiety of SPH acts specifically because it could be bound (possibly through hydrogen-bonding of interfacial residues) by either sPLA # residues at the lipid\water interface or competitively by cholesterol. Because the phosphocholine groups of PtdCho and SPH are identical it cannot be the only cause of the binding of sPLA # , but the suppression of the inhibitory activity of SPH after cleavage of the polar head group by treatment with sphingomyelinase suggests that there is a requirement for the phosphocholine group to bind the enzyme to the interface.
A number of studies with a variety of different substrates have established the inhibitory activity of the long chain base sphingosine. For example, Franson et al. [33] showed that sphingosine inhibits Ca# + -dependent phospholipase A # from Naja naja, pig pancreas, Crotalus adamanteus and human neutrophils in a dosedependent manner, with the IC &! ranging from 5 to 40 µM, with the use of [1-"%C]oleate-labelled autoclaved Escherichia coli or Candida albicans, or 1-acyl-2-[1-"%C]linoleoylglycerophosphoethanolamine or 1-acyl-2-[1-"%C]linoleoylglycerophosphocholine as the substrate. Subbaiah et al. [34] showed that lyso-SPH, which lacks the N-acyl group amidifying SPH, is as effective as SPH itself in inhibiting lecithin : cholesterol acyltransferase. On the basis of this observation we suggest that a co-operation involving the particular orientation of the phosphocholine group of SPH and the two hydrogen-bonding sites of the long-chain base probably constitutes a site of special affinity for sPLA # and various lipolytic enzymes. The relief by cholesterol of SPH inhibition points to a defined stoichiometry of SPH and cholesterol. A specificity confined to the inhibitory action of SPH is evident from the absence of any activating effect of cholesterol when the enzyme is assayed with the glycerophospholipid PtdEtn\PtdSer or PtdEtn\PtdSer\PtdCho mixtures (results not shown).
Physical heterogeneity of the substrate has been judged to be a favourable condition for PLA # activity [35] . Segregation of SPH\cholesterol in the substrate mixture could be an additional cause of increased susceptibility of the substrate. This condition is satisfied by most of the highly saturated molecular species of SPH at physiological temperatures and is thought to be relevant in biological membranes.
Finally, the present observations support the view that the structural default between SPH\cholesterol ' rafts ' and surrounding fluid glycerophospholipids could be the target for the enzyme in biological membranes. The interface between phaseseparated bilayers of SPH and fluid glycerophospholipid could not be hydrolysed when the enzyme was bound to SPH domains. We assume that SPH exerts its inhibitory potency via specific interactions with the interfacial binding site of sPLA #
. This interaction shows a stronger affinity than the interaction with glycerophospholipids. Hydrolytic activity was restored after cholesterol released sPLA # from its association with SPH. The present study paves the way for studies in i o, where inflammatory cytokines tumour necrosis factor α and interleukin 1β have been shown to induce simultaneous synthesis and secretion of sPLA # and sphingomyelinase [36] . A forward crossregulation can thereby be inferred.
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